Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shockwave IVL + DES

NCT: NCT05291247 · COMPLETED

NCT IDNCT05291247
StatusCOMPLETED
Start Date2022-07-22
Completion2026-02-10

Brief Summary

The objective of this clinical investigation is to evaluate, in a controlled setting, the 12 months safety and efficacy of the combination of Shockwave Intravascular Lithotripsy and a polymer coated Drug Eluting Stent device, for PACSS 3 and PACSS 4 calcified femoropopliteal disease.

Frequently Asked Questions

What is Shockwave IVL + DES?

Shockwave IVL + DES is a clinical trial registered under NCT05291247. Current status: COMPLETED.

What is the status of NCT05291247?

The current status of NCT05291247 (Shockwave IVL + DES) is: COMPLETED.

When did Shockwave IVL + DES start?

Shockwave IVL + DES started on 2022-07-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.